NTRB
Nutriband IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$47.73M
P/E Ratio
—
EPS
$-3.27
Beta
1.93
52W High
$11.68
52W Low
$3.42
50-Day MA
$4.16
200-Day MA
$5.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
370.37
PEG Ratio
—
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida.
Fundamentals
| Revenue (TTM) | $2.28M |
| Gross Profit (TTM) | 763,310 |
| EBITDA | $-9.03M |
| Operating Margin | -1121.00% |
| Return on Equity | -136.10% |
| Return on Assets | -55.20% |
| Revenue/Share (TTM) | $0.20 |
| Book Value | $0.62 |
| Price-to-Book | 6.10 |
| Price-to-Sales (TTM) | 20.95 |
| EV/Revenue | 17.99 |
| EV/EBITDA | -4.55 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -46.40% |
| Shares Outstanding | $12.17M |
| Float | $4.91M |
| % Insiders | 74.38% |
| % Institutions | 2.99% |
Data last updated: 4/9/2026